Citrate-buffered aqueous metal solutions for assay stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Metals tend to precipitate out of solution at physiological pH, making it difficult to effectively test cellular responses using stock solutions in assays.

Innovation Solution

A buffered aqueous solution is developed with a citrate component at concentrations ranging from 0.1 mM to 600 mM and a metal component at 0.01 mM to 100 mM, maintaining a pH between 5 and 9, which helps retain metals in solution and ensures cellular viability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If metals are placed in aqueous solution at physiological pH, then the solution is suitable for cellular assays, but the metals precipitate out of solution

Engineering Contradiction:
Improvemetal solubilityVSAvoidassay feasibility
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

Citrate acts as a chelating intermediary between metal ions and water molecules. The citrate molecule forms stable complexes with metal ions through coordination bonds, preventing metal hydroxide precipitation while maintaining metal bioavailability. This intermediary mechanism allows metals to remain in solution at physiological pH without requiring extreme pH adjustments or specialized containers.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Duration of action of stationary object

If citrate is added to maintain metal solubility, then metals remain in solution longer, but the buffer composition becomes more complex

Engineering Contradiction:
Improvemetal solution stabilityVSAvoidbuffer composition
Core Design Contradiction:
Duration of action of stationary objectVSDevice complexity

Solution Approach 1:

The patent optimizes citrate concentration parameters within specific ranges (0.1-600 mM) to achieve effective metal chelation while maintaining physiological compatibility. By adjusting citrate-to-metal ratios and controlling pH within 5-9, the system achieves long-term stability without requiring multiple additives or complex buffering systems. This parameter optimization simplifies the overall buffer composition compared to alternative approaches.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS11119094B2Aqueous citrate-buffered metal solutions
Publication Date: 2021.09.14 CD DIAGNOSTICS INC
  • US11119094B2 patent drawing
  • US11119094B2 patent drawing
  • US11119094B2 patent drawing

AI summary

Various embodiments disclosed relate to a buffered aqueous solution. The buffered aqueous solution includes a buffer. The buffer includes a citrate component having a concentration in the solution in a range of from about 0.1 mM to about 600 mM. The buffer further includes a metal component having a concentration in the solution in a range of from about 0.01 mM to about 100 mM. The buffered aqueous solution has a pH in a range of from about 5 to about 9.